241 related articles for article (PubMed ID: 37242570)
1. An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas.
Liu WT; Wang HT; Yeh YH; Wong TW
Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242570
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Kim EJ; Mangold AR; DeSimone JA; Wong HK; Seminario-Vidal L; Guitart J; Appel J; Geskin L; Lain E; Korman NJ; Zeitouni N; Nikbakht N; Dawes K; Akilov O; Carter J; Shinohara M; Kuzel TM; Piette W; Bhatia N; Musiek A; Pariser D; Kim YH; Elston D; Boh E; Duvic M; Huen A; Pacheco T; Zwerner JP; Lee ST; Girardi M; Querfeld C; Bohjanen K; Olsen E; Wood GS; Rumage A; Donini O; Haulenbeek A; Schaber CJ; Straube R; Pullion C; Rook AH; Poligone B
JAMA Dermatol; 2022 Sep; 158(9):1031-1039. PubMed ID: 35857290
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic Therapy as an Effective Treatment for Cutaneous Lymphomas.
Caccavale S; Tancredi V; Vitiello P; Sica A; Ronchi A; Franco R; Pastore F; Argenziano G
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678676
[TBL] [Abstract][Full Text] [Related]
4. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
[TBL] [Abstract][Full Text] [Related]
6. Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F; Pujol RM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291756
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of cutaneous T-cell lymphoma cell lines mediated by 5-aminolevulinic acid and derivatives.
Vallecorsa P; Di Venosa G; Gola G; Sáenz D; Mamone L; MacRobert AJ; Ramírez J; Casas A
J Photochem Photobiol B; 2021 Aug; 221():112244. PubMed ID: 34174487
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
9. [Photodynamic therapy of cutaneous T-cell lymphoma at special sites].
Eich D; Eich HT; Otte HG; Ghilescu V; Stadler R
Hautarzt; 1999 Feb; 50(2):109-14. PubMed ID: 10097953
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
[TBL] [Abstract][Full Text] [Related]
11. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphomas-An update 2021.
Kempf W; Mitteldorf C
Hematol Oncol; 2021 Jun; 39 Suppl 1():46-51. PubMed ID: 34105822
[TBL] [Abstract][Full Text] [Related]
14. [Rare variants of cutaneous T-cell lymphomas].
Goerdt S; Trautmann C; Kütting B; Ramaker J; Schmuth M; Thiel E; Luger T; Stein H; Orfanos CE
Hautarzt; 1996 Feb; 47(2):96-105. PubMed ID: 8868452
[TBL] [Abstract][Full Text] [Related]
15. Thirty years of progress in cutaneous lymphoma research.
Willemze R
G Ital Dermatol Venereol; 2012 Dec; 147(6):515-21. PubMed ID: 23149697
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification.
Willemze R
Presse Med; 2022 Mar; 51(1):104126. PubMed ID: 35569698
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous T-cell lymphomas in childhood and adolescence.
Wohlmuth-Wieser I
J Dtsch Dermatol Ges; 2021 Apr; 19(4):563-581. PubMed ID: 33861015
[TBL] [Abstract][Full Text] [Related]
18. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
20. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas.
Dommann SN; Dommann-Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G
Am J Dermatopathol; 1997 Aug; 19(4):391-5. PubMed ID: 9261475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]